Cargando…
Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
Myeloid Derived Suppressor Cell (MDSC) has been raised to be a novel target for multiple cancers. However, target agents on MDSC have not display promising efficacy. One of the critical reasons shall be less optimal patient selection. In the present study, we aimed to identify clinical parameters re...
Autores principales: | Li, Xing, Xing, Yan-Fang, Lei, Ai-Hua, Xiao, Qiang, Lin, Zhi-Huan, Hong, Ying-Fen, Wu, Xiang-Yuan, Zhou, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421855/ https://www.ncbi.nlm.nih.gov/pubmed/28412745 http://dx.doi.org/10.18632/oncotarget.15456 |
Ejemplares similares
-
The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis
por: Zhang, Xinyu, et al.
Publicado: (2019) -
Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
por: Wang, Yijun, et al.
Publicado: (2021) -
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022) -
Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023) -
Editorial: Myeloid-derived suppressor cells in inflammation and its complications and cancers
por: Li, Xing, et al.
Publicado: (2023)